首页> 外文期刊>BMC Health Services Research >Patient delay in cancer studies: a discussion of methods and measures
【24h】

Patient delay in cancer studies: a discussion of methods and measures

机译:癌症研究中的患者延误:方法和措施的讨论

获取原文
           

摘要

Background There is no validated way of measuring the prevalence and duration of patient delay, and we do not know how people perceive and define the time intervals they are asked to report in patient delay studies. This lack of a validated measure hampers research in patient delay and is counterproductive to efforts directed at securing early diagnosis of cancer. Discussion The main argument of the present paper is that current studies on patient delay do not sufficiently consider existing theories on symptom interpretation. It is illustrated that the interpretation of bodily sensations as symptoms related to a specific cancer diagnosis is embedded within a social and cultural context. We therefore cannot assume that respondents define delay periods in identical ways. Summary In order to improve the validity of patient delay studies, it is suggested that research be strengthened on three counts: More research should be devoted to symptom interpretation processes, more research should seek to operationalise patient delay, and, importantly, more research is needed to develop valid instruments for measuring patient delay.
机译:背景技术目前尚无有效的方法来衡量患者延误的发生率和持续时间,而且我们不知道人们如何感知和定义患者延误研究中要求报告的时间间隔。这种缺乏有效措施的研究阻碍了患者延误的研究,并且与旨在确保癌症早期诊断的努力适得其反。讨论本文的主要论点是,目前有关患者延误的研究并未充分考虑现有的症状解释理论。可以说明,将身体感觉解释为与特定癌症诊断有关的症状,是一种社会和文化背景。因此,我们不能假设受访者以相同的方式定义延迟时间。总结为了提高患者延误研究的有效性,建议加强以下三个方面的研究:更多的研究应用于症状解释过程,更多的研究应寻求对患者延误进行操作,重要的是,还需要更多的研究。开发有效的仪器来测量患者的延迟。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号